Diagnosed incident melanoma cases across the eight major markets (8MM) are projected to increase from 229,000 in 2025 to 263,000 in 2035. According to GlobalData's latest Melanoma: Epidemiology Report and Forecast, the United States is projected to record the highest number of diagnosed incident melanoma cases, with more than 130,000 cases by 2035. Canada is expected to report around 14,000 cases, Australia approximately 21,000, and the five major European markets (5EU) about 88,000 cases over the same period. The report also said that Stage 1 accounted for the largest share of diagnosed incident melanoma cases across all eight markets, although proportions varied by country. The eight major markets (8MM) comprise the US, France, Germany, Italy, Spain, the UK, Canada, and Australia.